Biotech Firm Organovo Moves HQ to New 16 KSF Facility

By Alex Girda, Associate Editor Biotechnology firm Organovo Holdings, Inc., has relocated to a larger facility in San Diego facility. Noted for its innovative three-dimensional bioprinting technology, Organovo has leased 15,539 square feet in the city’s Sorrento Mesa area. The new space will be almost four times as large as the company’s previous headquarters and [...]

Biotechnology firm Organovo Holdings, Inc., has relocated to a larger facility in San Diego facility. Noted for its innovative three-dimensional bioprinting technology, Organovo has leased 15,539 square feet in the city’s Sorrento Mesa area.

The new space will be almost four times as large as the company’s previous headquarters and will provide mixed laboratory and office space as well as new clean room space. Financial terms of the deal arranged with landlord Alexandria Real Estate Equities Inc. by Cushman & Wakefield Inc. on Organovo’s behalf were not disclosed.

Organovo’s chairman and CEO, Keith Murphy, has described the new facility as “a state-of-the-art space for our team to drive innovation with our research and development initiatives and supports partnering activities with our bioprinting technologies.”

Alexandria Real Estate Equities’ San Diego-area holdings encompass about 2.6 million square feet occupied by life sciences-related tenants. Organovo’s achievements include the selection of its NovoGen MMX Bioprinter by TIME Magazine for its list of the “Best Inventions of 2010.”